Evidence map›Paper›PMID 32757686›Full record

ArticleLeukemia & lymphoma2020

Machine learning derived genomics driven prognostication for acute myeloid leukemia with

Anam Fatima Shaikh, Chinmayee Kakirde, Chetan Dhamne, Prasanna Bhanshe, Swapnali Joshi, Shruti Chaudhary, Gaurav Chatterjee, Prashant Tembhare, Maya Prasad, Nirmalya Roy Moulik and 14 more

Open access · hybridAbstract read
In one paragraph

Article in Leukemia & lymphoma, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 3 institutions in 1 country.

Anam Fatima ShaikhHaematopathology Laboratory, ACTREC, Tata Memorial Centre, Navi Mumbai, India.
Chinmayee KakirdeHaematopathology Laboratory, ACTREC, Tata Memorial Centre, Navi Mumbai, India.
Chetan DhamneHomi Bhabha National Institute (HBNI), Mumbai, India.
Prasanna BhansheHaematopathology Laboratory, ACTREC, Tata Memorial Centre, Navi Mumbai, India.
Swapnali JoshiHaematopathology Laboratory, ACTREC, Tata Memorial Centre, Navi Mumbai, India.
Shruti ChaudharyHaematopathology Laboratory, ACTREC, Tata Memorial Centre, Navi Mumbai, India.
Gaurav ChatterjeeHaematopathology Laboratory, ACTREC, Tata Memorial Centre, Navi Mumbai, India.
Prashant TembhareHaematopathology Laboratory, ACTREC, Tata Memorial Centre, Navi Mumbai, India.
Maya PrasadHomi Bhabha National Institute (HBNI), Mumbai, India.
Nirmalya Roy MoulikHomi Bhabha National Institute (HBNI), Mumbai, India.
Anant GokarnHomi Bhabha National Institute (HBNI), Mumbai, India.
Avinash BondaHomi Bhabha National Institute (HBNI), Mumbai, India.
Lingaraj NayakHomi Bhabha National Institute (HBNI), Mumbai, India.
Sachin PunatkarHomi Bhabha National Institute (HBNI), Mumbai, India.
Hasmukh JainHomi Bhabha National Institute (HBNI), Mumbai, India.
Bhausaheb BagalHomi Bhabha National Institute (HBNI), Mumbai, India.
Dhanalaxmi ShettyDeparment of Cytogenetics, ACTREC, Tata Memorial Centre, Navi Mumbai, India.
Manju SengarHomi Bhabha National Institute (HBNI), Mumbai, India.
Gaurav NarulaHomi Bhabha National Institute (HBNI), Mumbai, India.
Navin KhattryHomi Bhabha National Institute (HBNI), Mumbai, India.
Shripad BanavaliHomi Bhabha National Institute (HBNI), Mumbai, India.
Sumeet GujralHaematopathology Laboratory, ACTREC, Tata Memorial Centre, Navi Mumbai, India.
Subramanian P GHaematopathology Laboratory, ACTREC, Tata Memorial Centre, Navi Mumbai, India.
Nikhil PatkarHaematopathology Laboratory, ACTREC, Tata Memorial Centre, Navi Mumbai, India.
Tata Memorial Hospital · INHomi Bhabha National Institute · INAdvanced Centre for Treatment, Research and Education in Cancer · IN

Funding

Wellcome Trust
6 · The paper itself

Abstract

Panel based next generation sequencing was performed on a discovery cohort of AML with

Indexed as

Core Binding Factor Alpha 2 SubunitLeukemia, Myeloid, AcuteGenomicsHumansMachine LearningMutationRUNX1 Translocation Partner 1 ProteinCore Binding Factor Alpha 2 SubunitRUNX1 protein, humanRUNX1T1 protein, humanRUNX1 Translocation Partner 1 ProteinAcute myeloid leukemia (AML) with RUNX1-RUNX1T1gene mutations in AML with RUNX1-RUNX1T1gene mutations in AML with t(8;21)genomic risk stratificationmachine learning

Identifiers

PMID32757686
PMCPMC7116445
OpenAlexW3048096596

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.